ForSight Robotics
ForSight Robotics raises $125M Series B at $700M valuation
Quick Facts
ForSight Robotics: Series B Funding Round
ForSight Robotics has successfully raised $125M in Series B funding, reaching a valuation of $700M.
Company Overview
Ophthalmic surgical robots
Funding Details
The Series B round was led by Eclipse Ventures, with participation from Vensana Capital.
Company Information
- Headquarters: Menlo Park, CA
- Founded: 2018
- Employees: 200+
- Category: MedTech
Investment
ForSight Robotics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Eclipse Ventures: Verified investor in Series B
- Vensana Capital: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
NeuroLink Brain Raises $580M Series D to Transform Healthcare
NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.
MedTech Revolution Secures $890M Series D to Lead MedTech Innovation
MedTech Revolution raises $890M in Series D funding at $13.7B valuation to complete clinical trials for 5 medical devices, scale robotic surgery systems, and expand to asian markets.
CMR Surgical raises $200M Series D at $3B valuation
CMR Surgical raises $200M in Series D at $3B valuation. Surgical robotic systems...